H.R. 10850House119th Congress (2025-2027)In Committee

SCREENS Act

To amend the Public Health Service Act to require the National Coordinator for Health Information Technology to establish a national computable-guideline framework for cancer screening recommendations, and for other purposes.

Also known as Standardizing Cancer Recommendations for Earlier Evaluation and Navigation of Screenings Act

Introduced October 19, 2026

AI-Generated Summary

Updated October 20, 2026 at 9:51 AM UTC

The SCREENS Act amends the Public Health Service Act to create a national, computer‑readable set of cancer‑screening guidelines. It directs the National Coordinator for Health IT, together with key health agencies, to develop and annually update this framework and to make the recommendations available in a format that health‑IT systems can use. The law also requires certified health‑IT products to include tools that can tell whether a patient is up‑to‑date on recommended screenings, and it pushes health plans to adopt such technology while protecting patient privacy.

Key Provisions

  • Within one year, the National Coordinator must work with agencies like the USPSTF and NCI to build a national, computable‑guideline framework for cancer‑screening recommendations, updated each year.
  • The framework’s recommendations must be published in a machine‑readable format that works with standard oncology data sets (mCODE) or the US Core Data for Interoperability.
  • Privacy safeguards must be followed, prohibiting unauthorized use or re‑identification of personal health data.
  • Within five years, health‑IT certification rules must require that certified systems include functionality to determine a patient’s cancer‑screening status using the framework, using only minimal necessary data and providing clear patient information and access rights.
  • Within two years, HHS must issue guidance encouraging Medicaid, Medicare Advantage, and marketplace health plans to adopt technology that operationalizes these guidelines and lets consumers opt into certified EHRs with the new functionality.
  • The Patient‑Centered Outcomes Research Institute may fund research, pilots, and dissemination projects to develop and test interoperable tools, decision aids, and clinical‑decision support that apply the computable cancer‑screening guidelines.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

1 earlier action
HouseIntro Referral Latest Action

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

October 19, 2026

View full timeline
HouseIntro Referral

Introduced in House

October 19, 2026

HouseIntro Referral

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

October 19, 2026

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in HouseIssued October 19, 2026

I

119th CONGRESS

2d Session

H. R. 10850

IN THE HOUSE OF REPRESENTATIVES

October 19, 2026

Mrs. Hinson (for herself and Ms. Scholten) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend the Public Health Service Act to require the National Coordinator for Health Information Technology to establish a national computable-guideline framework for cancer screening recommendations, and for other purposes.

1.

Short title

This Act may be cited as the Standardizing Cancer Recommendations for Earlier Evaluation and Navigation of Screenings Act or the SCREENS Act.

2.

National computable-guideline framework for cancer screening recommendations

(a)

In general

Subtitle A of title XXX of the Public Health Service Act (42 U.S.C. 300jj–11 et seq.) is amended by adding at the end the following:

3009B.

National computable-guideline framework for cancer screening recommendations

(a)

In general

Not later than 1 year after the date of enactment of the Standardizing Cancer Recommendations for Earlier Evaluation and Navigation of Screenings Act, the National Coordinator, in consultation with the Director of the Agency for Healthcare Research and Quality, the United States Preventive Services Task Force, the Director of the National Cancer Institute, the Director of the Centers for Disease Control and Prevention, and key oncology stakeholders, shall establish a national computable-guideline framework for cancer screening recommendations based on data and certain statistics, such as age, sex, and high-risk factors, established in the recommendations of the United States Preventive Services Task Force and the National Cancer Institute. Such framework shall be updated annually.

(b)

Requirement

(1)

In general

The recommendations contained in the framework under subsection (a) shall be publicly available in machine-readable screening logic, so that interoperability and health information technology can use such recommendations to establish patient-forward technologies for the purpose of making such recommendations more accessible and consumer-focused.

(2)

Machine-readable screening logic interoperability requirement

The machine-readable screening logic required under paragraph (1) shall be interoperable with—

(A)

the Minimal Common Oncology Data Elements (mCODE) dataset; or

(B)

the United States Core Data for Interoperability (USCDI).

(c)

Privacy protections

The National Coordinator shall ensure that all activities conducted pursuant this section comply with applicable privacy laws, including the regulations promulgated under section 264(c) of the Health Insurance Portability and Accountability Act of 1996.

(d)

Effect

Nothing in this Act permits the unauthorized use, disclosure, or re-identification of individually identifiable health information.

.

(b)

Condition of certification

Section 3001(c)(5) of the Public Health Service Act (42 U.S.C. 300jj–11(c)(5)) is amended—

(1)

by redesignating subparagraph (E) as subparagraph (F);

(2)

by inserting after subparagraph (D) the following:

(E)

Condition of certification relating to cancer screening recommendations

(i)

In general

Not later than 5 years after the date of enactment of the Standardizing Cancer Recommendations for Earlier Evaluation and Navigation of Screenings Act, the Secretary, through notice and comment rulemaking, shall require, as a condition of certification and maintenance of certification for programs maintained or recognized under this paragraph, consistent with other conditions and requirements under this title, that the health information technology will include functionality that operationalizes the cancer screening recommendations included in the national computable-guideline framework established under section 3009B(a) so that the status of an individual patient with respect to completion of recommended cancer screenings may be determined.

(ii)

Privacy protections

The functionality required under clause (i) shall—

(I)

use only the minimum necessary patient data, including age, sex, and high-risk factors, required to determine an individual’s status with respect to recommended cancer screenings;

(II)

provide patients with clear and accessible information regarding how their data is used in generating cancer screening recommendations; and

(III)

support mechanisms for patients to access, review, and request changes to their health information, in accordance with applicable privacy laws.

; and

(3)

in subparagraph (F) (as so redesignated), by striking subparagraph (D) and inserting subparagraphs (D) and (E).

3.

Guidance relating to integration of computable-guideline cancer screening recommendations into health plans

(a)

In general

Not later than 2 years after the date of enactment of this Act, the Secretary of Health and Human Services shall issue guidance to encourage health plans—

(1)

to integrate technology that operationalizes the cancer screening recommendations included in the national computable-guideline framework established under section 3009B(a) of the Public Health Service Act (as added by section 2(a)); and

(2)

to enable consumers to opt into certified EHR technology (as defined in section 3000 of the Public Health Service Act (42 U.S.C. 300jj)) that includes the functionality for cancer screening recommendations described in subparagraph (E) of section 3001(c)(5) of such Act (42 U.S.C. 300jj–11(c)(5)).

(b)

Definition of health plan

In this section, the term health plan means—

(1)

a medicaid managed care organization (as defined in section 1903(m)(1)(A) of the Social Security Act (42 U.S.C. 1396b(m)(1)(A))) or other specified entity (as defined in section 1903(m)(9)(D) of the Social Security Act (42 U.S.C. 1396b(m)(9)(D)));

(2)

a Medicare Advantage plan under part C of title XVIII of the Social Security Act (42 U.S.C. 1395w–21 et seq.); or

(3)

a qualified health plan offered through the American Health Benefit Exchanges established under sections 1311 and 1321 of the Patient Protection and Affordable Care Act (42 U.S.C. 18031, 18041).

4.

Patient-Centered Outcomes Research Institute research, pilot projects, implementation activities, and dissemination efforts

Section 1181(d)(1) of the Social Security Act (42 U.S.C. 1320e(d)(1)) is amended by adding at the end the following new subparagraph:

(C)

Research, pilot projects, implementation activities, and dissemination efforts

The Institute may support research, pilot projects, implementation activities, and dissemination efforts that advance the use of interoperable health information technology to improve patient-centered outcomes through the translation of evidence-based preventive care recommendations into clinical practice. Such activities may include the development, testing, evaluation, and implementation of computable clinical guidelines, clinical decision support tools, patient-facing decision aids, and interoperable technologies that facilitate evidence-based cancer screening recommendations, shared decision making, and identification of individuals who may be eligible for preventive services or clinical research.

.